Dario Conti, Nicolaja Girone, Maria Boscacci, Lorenzo Casati, Niccolò Cassina, Lucia Cerolini, Luca Giacovelli, Caterina Viganò, Marian Mora Conde, Laura Cremaschi, Bernardo M Dell'Osso
Obsessive-compulsive disorder (OCD) is a chronic disease with a prevalence in the general population of around 2%-3%, generally accompanied by a severe impairment of functioning and quality of life. A consistent subgroup of patients may not achieve adequate symptom remission with first-line treatments (i.e., cognitive behavioral therapy, selective serotonin reuptake inhibitors [SSRIs]). The most validated option for treatment-resistant cases relies on the augmentative use of antipsychotics to SSRIs, preferably of the 'second generation'...
February 10, 2024: Human Psychopharmacology